{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:46:34Z","timestamp":1787903194007,"version":"build-2784847793"},"reference-count":34,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Milken Family Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Psoriasis is a chronic inflammatory skin disease with a variable course. Early identification of patients likely to require biologic therapy may help reduce complications and optimize care. In this study, we developed machine learning (ML) models to predict future biologic therapy use in psoriasis patients. Methods: We conducted a retrospective study using electronic health records (EHR) from Clalit Health Services in Israel, including psoriasis patients who started biologic therapy and matched psoriasis controls. Predictors included demographics, comorbidities, treatment history, and laboratory test results. KNN, SVM, Random Forest, and Logistic Regression ML models were trained on data from either the first five years post-onset or the five years preceding biologic therapy. Performance was evaluated on a held-out test set using AUC-ROC, precision, recall, and F1-score, with an emphasis on recall to maximize identification of true positive cases. Results: The best-performing models incorporated clinical, demographic, and laboratory data. Using data from the first five years after onset, the SVM model achieved the highest performance (AUC = 0.83, recall = 0.7). For data from the five years preceding biologic therapy, the Random Forest model performed best (AUC = 0.93, recall = 0.95). Key predictors included comorbid immune-mediated conditions, topical treatment frequency, and markers of inflammation and metabolism. Conclusions: EHR-based ML models, particularly those incorporating routine laboratory, demographic, and clinical data, can effectively predict future biologic therapy use in psoriasis patients. Model performance may be improved with larger cohorts and more complete clinical and laboratory data.<\/jats:p>","DOI":"10.3390\/jcm14186421","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T15:10:46Z","timestamp":1757603446000},"page":"6421","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early Risk Prediction for Biologic Therapy in Psoriasis Using Machine Learning Models Based on Routine Health Records"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7873-7815","authenticated-orcid":false,"given":"Tair","family":"Lax","sequence":"first","affiliation":[{"name":"Department of Molecular Biology, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noga","family":"Fallach","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4355-7566","authenticated-orcid":false,"given":"Edia","family":"Stemmer","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Shrem","sequence":"additional","affiliation":[{"name":"Fertility Clinic, Clalit Health Services, Migdal HaEmek 2303001, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7272-0846","authenticated-orcid":false,"given":"Mali","family":"Salmon-Divon","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Ariel University, Ariel 4070000, Israel"},{"name":"Adelson School of Medicine, Ariel University, Ariel 4070000, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, Clinical Presentation, and Treatment of Psoriasis","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_3","first-page":"CD011972","article-title":"Lifestyle Changes for Treating Psoriasis","volume":"2019","author":"Ko","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Nicolescu, A.C., Ionescu, M.-A., Constantin, M.M., Ancuta, I., Ionescu, S., Niculet, E., Tatu, A.L., Zirpel, H., and Tha\u00e7i, D. (2022). Psoriasis Management Challenges Regarding Difficult-to-Treat Areas: Therapeutic Decision and Effectiveness. Life, 12.","DOI":"10.3390\/life12122050"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jamadermatol.2022.3171","article-title":"Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients with Psoriasis at the Individual Level","volume":"158","author":"Nielsen","year":"2022","journal-title":"JAMA Dermatol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/bjd.18741","article-title":"Predicting the Long-term Outcomes of Biologics in Patients with Psoriasis Using Machine Learning","volume":"182","author":"Emam","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jaad.2022.12.046","article-title":"Machine Learning Model for Predicting Outcomes of Biologic Therapy in Psoriasis","volume":"88","author":"Du","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Choi, Y.I., Park, S.J., Chung, J.-W., Kim, K.O., Cho, J.H., Kim, Y.J., Lee, K.Y., Kim, K.G., Park, D.K., and Kim, Y.J. (2020). Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113427"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Sch\u00f6ler, D., Kostev, K., Peters, M., Zamfir, C., Wolk, A., Roderburg, C., and Loosen, S.H. (2022). Machine Learning Can Predict the Probability of Biologic Therapy in Patients with Inflammatory Bowel Disease. J. Clin. Med., 11.","DOI":"10.3390\/jcm11154586"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zhou, J., Li, Y., and Guo, X. (2021). Predicting Psoriasis Using Routine Laboratory Tests with Random Forest. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0258768"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-021-02714-5","article-title":"Characterizing Memory T Helper Cells in Patients with Psoriasis, Subclinical, or Early Psoriatic Arthritis Using a Machine Learning Algorithm","volume":"24","author":"Razawy","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/ced\/llae348","article-title":"Predicting Psoriasis Severity Using Machine Learning: A Systematic Review","volume":"50","author":"McMullen","year":"2025","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.2147\/CCID.S439110","article-title":"Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review","volume":"16","author":"Wang","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/art.41946","article-title":"Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case\u2013Control Study","volume":"74","author":"Rosenthal","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3899\/jrheum.2023-0506","article-title":"Can Early Aggressive Treatment of Psoriasis Prevent Psoriatic Arthritis? A Debate at the GRAPPA Annual Meeting","volume":"50","author":"Soriano","year":"2023","journal-title":"J. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/rheumatology\/keae257","article-title":"Treatment of Psoriasis with Different Classes of Biologics Reduces the Likelihood of Peripheral and Axial Psoriatic Arthritis Development","volume":"64","author":"Floris","year":"2025","journal-title":"Rheumatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/14712598.2023.2273269","article-title":"Does Pharmacological Intervention Prevent or Delay the Onset of Psoriatic Arthritis among Psoriasis Patients?","volume":"23","author":"Loredo","year":"2023","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_18","first-page":"126","article-title":"Association between Mean Platelet Volume and Disease Severity in Patients with Psoriasis and Psoriatic Arthritis","volume":"34","author":"Oymak","year":"2017","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tampa, M., Mitran, M.I., Mitran, C.I., Matei, C., and Georgescu, S.R. (2024). Psoriasis: What Is New in Markers of Disease Severity?. Med. Buenos Aires, 60.","DOI":"10.3390\/medicina60020337"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.36849\/JDD.6127","article-title":"Platelet Count, Mean Platelet Volume, and Red Cell Distribution Width as Markers for Psoriasis Severity","volume":"21","author":"Nageen","year":"2022","journal-title":"J. Drugs Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11154-017-9411-6","article-title":"Vitamin D and Its Role in Psoriasis: An Overview of the Dermatologist and Nutritionist","volume":"18","author":"Barrea","year":"2017","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Formisano, E., Proietti, E., Borgarelli, C., and Pisciotta, L. (2023). Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis. Nutrients, 15.","DOI":"10.3390\/nu15153387"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5114\/dr.2024.140793","article-title":"Association of Serum Calcium Level and Serum Uric Acid Level in Psoriasis and Its Correlation with Severity of Psoriasis","volume":"111","author":"Ambike","year":"2024","journal-title":"Dermatol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20184467","article-title":"Correlation of Serum Calcium Levels with Severity of Psoriasis","volume":"4","author":"Chaudhari","year":"2018","journal-title":"Int. J. Res. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0923-1811(90)90120-3","article-title":"Inverse Relation between Severity of Psoriasis and Serum 1,25-Dihydroxyvitamin D Level","volume":"1","author":"Morimoto","year":"1990","journal-title":"J. Dermatol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hicks, S.A., Str\u00fcmke, I., Thambawita, V., Hammou, M., Riegler, M.A., Halvorsen, P., and Parasa, S. (2022). On Evaluation Metrics for Medical Applications of Artificial Intelligence. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-09954-8"},{"key":"ref_27","first-page":"EC13","article-title":"A Correlative Study between Platelet Count, Mean Platelet Volume and Red Cell Distribution Width with the Disease Severity Index in Psoriasis Patients","volume":"11","author":"Raghavan","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijnpnd.ijnpnd_68_21","article-title":"Comparative and Correlative Study of Hematologic Parameters and Selective Inflammatory Biomarkers in Psoriasis","volume":"12","author":"Arunadevi","year":"2022","journal-title":"Int. J. Nutr. Pharmacol. Neurol. Dis."},{"key":"ref_29","first-page":"e43790","article-title":"The Relationship of Hematological Parameters and C-Reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients with Psoriasis","volume":"15","author":"Karaman","year":"2023","journal-title":"Cureus"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tiuc\u0103, O.M., Morariu, S.H., Mariean, C.R., Tiuc\u0103, R.A., Nicolescu, A.C., and Cotoi, O.S. (2024). Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression. Life, 14.","DOI":"10.3390\/life14010114"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis Alters HDL Composition and Cholesterol Efflux Capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J. Lipid Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5114\/aoms.2018.74021","article-title":"Serum Lipid Metabolism in Psoriasis and Psoriatic Arthritis\u2014An Update","volume":"15","author":"Pietrzak","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1590\/1806-9282.64.04.368","article-title":"Metabolic Syndrome and Psoriasis: A Study in 97 Patients","volume":"64","author":"Ferdinando","year":"2018","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Lax, T., Stemmer, E., Fallach, N., Shrem, G., Schreiber-Divon, M., Ayalon, S., Giat, E., Mor, I., and Salmon-Divon, M. (2025). Exploring the Impact of Gender and Age of Onset on Psoriasis Treatment Management. J. Clin. Med., 14.","DOI":"10.20944\/preprints202505.0509.v1"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6421\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:44:09Z","timestamp":1760035449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":34,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14186421"],"URL":"https:\/\/doi.org\/10.3390\/jcm14186421","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}